THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Newbridge Financial Services Group, Inc.'s Holding History (CIK: 0001879757)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 1,000 Value ($000) $9 Avg Close $9.27 Range $8.21 - $11.71
Q4 2023
Shares 1,000 Value ($000) $11 Avg Close $10.06 Range $8.52 - $11.57
Q3 2023
Shares 1,000 Value ($000) $9 Avg Close $9.65 Range $8.25 - $10.59
Q2 2023
Shares 1,000 Value ($000) $10 Avg Close $11.04 Range $9.98 - $12.03
Q1 2023
Shares 2,000 Value ($000) $22 Avg Close $10.57 Range $9.25 - $11.52
Q4 2022
Shares 2,000 Value ($000) $22 Avg Close $10.51 Range $9.56 - $11.83
Q3 2022
Shares 2,000 Value ($000) $20 Avg Close $9.37 Range $7.53 - $11.00
Q2 2022
Shares 2,000 Value ($000) $18 Avg Close $9.21 Range $8.15 - $10.52
Q1 2022
Shares 2,000 Value ($000) $19 Avg Close $9.80 Range $7.71 - $13.17
Q4 2021
Shares 2,000 Value ($000) $22 Avg Close $8.72 Range $7.30 - $11.24
Q3 2021
Shares 2,000 Value ($000) $15 Avg Close $11.19 Range $6.10 - $15.01
Q2 2021
Shares 2,000 Value ($000) $29 Avg Close $18.78 Range $14.46 - $22.74